Fomitopsis officinalis

English name Agarikon

Developed for: COVID-19
Investigated by: Gordon Saxe · University of California, Irvine · University of California, Los Angeles

today NCT04667247 · Ph 1/2

202120222023202420252026

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1/2	NCT04667247	Dec 2020 → Mar 2022	COVID-19	Gordon Saxe	Completed	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Fomitopsis officinalis	“This is a multi-center, randomized, double-blind, placebo-controlled clinical trial to evaluate two polypore mushrooms, Fomitopsis officinalis and Trametes versicolor (FoTv),...” NCT04667247 ↗